PERSPECTA

News from every angle

← Back to headlines

Jefferies Maintains 'Buy' Rating on Eli Lilly and Company (LLY)

Jefferies has reiterated its 'Buy' rating for pharmaceutical giant Eli Lilly and Company (LLY).

29 Mar, 20:15 — 29 Mar, 20:15
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual2h ago

Jefferies Remains a Buy on Eli Lilly and Company (LLY)

Read full article →

Related Stories

Icelandic Hospital CEO Reflects on Epidemic Response

25m ago

Bristol Myers Drug Shows Promise for Rare Pediatric Heart Condition

27m ago

Violent Fire Breaks Out in German Club, 750 Evacuated

36m ago

Why you should never peel the white layer of an orange

46m ago